Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023243 · ClinicalTrials.gov registry record · NA
Natural Language Processing and Quality Assessment in Primary Care
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 389
- Enrollment target
NCT01023243: Completed NA study, sponsored by Mayo Clinic.
NCT01023243 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 389 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023243, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 389 participants
- Enrollment target
Study Summary
The investigators propose to use a Natural Language Processing System (NLP) to provide an initial baseline report for primary care patients at risk for diabetes and cardiovascular complications that will include: a) evidence of foot exam documentation in the previous year; b) use of aspirin for cardiovascular risk reduction; and c) tobacco use. As part of a randomized trial, we plan to use a previously validated mailed survey (NCQA Provider Recognition Program) that requests information on the last foot exam, use of aspirin and tobacco. Patients who have been identified by NLP as not having had a foot exam will be randomized into treatment and control arms. Both arms will receive an informational letter; with a second mailing to nonresponders after one month, describing the key strategies for effective patient-physician communication during the clinical encounter. The treatment arm will also receive an informational letter and patient education brochure containing key messages about the importance of regular foot examinations. NLP will be repeated after 6 months to compare the impact of the patient education materials.
Interventions
- OTHER Brochure: Care of the Feet for Those at Risk
- OTHER Quality Survey: foot exam, tobacco and aspirin use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 389 participants |
| Start Date | 2010-01 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT01023243 record still lists
NCT01023243 is an interventional study that assigns participants to a tested intervention. The registered 389 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Brochure: Care of the Feet for Those at Risk is the first listed.
NCT01023243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01023243 about?
NCT01023243 is a clinical study titled "Natural Language Processing and Quality Assessment in Primary Care". The investigators propose to use a Natural Language Processing System (NLP) to provide an initial baseline report for primary care patients at risk for diabetes and cardiovascular complications that will include: a) evidence of foot exam documentation in the previous year; b) use of aspirin for card...
What is the current status of trial NCT01023243?
This trial is currently completed. It is a NA study. The enrollment target is 389 participants. The study started on 2010-01. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01023243?
The interventions under investigation include: Brochure: Care of the Feet for Those at Risk (OTHER), Quality Survey: foot exam, tobacco and aspirin use (OTHER).
Who is sponsoring clinical trial NCT01023243?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01023243's enrollment target sits among peer trials
389 270th of 2000 higher than 1,731 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05431088 · 389 participants · Phase 2
A Phase 2/3 Study in Adult and Adolescent Participants With SCD
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia